Myriad Genetics, Inc. (MYGN)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$6.49
+3.18%
Mkt Cap $532.77M
Analyst Ratings
Buy
1
Hold
7
Sell
1
Price Target (24 analysts)
$4.82
Range $3.00 – $8.00
Implied Upside
-25.7%
Consensus $4.82 vs current $6.49